Compare Bristol-Myers Squibb Co (BMY) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Public Storage — how do they compare? Bristol-Myers Squibb Co trades at $57 (market cap $116.30B), while Public Storage trades at $318.01 (market cap $56.00B). The key difference: Bristol-Myers Squibb Co is far larger — about 2.1× Public Storage's market cap, and Bristol-Myers Squibb Co pays the higher dividend (4.42%). Which is the better fit depends on your goals.
| BMY | PSA | |
|---|---|---|
Market Cap | $116.30B | $56.00B |
Sector | Health | Real Estate |
52-Week High | $62.37 | $329.64 |
52-Week Low | $42.60 | $258.44 |
Enterprise Value | $152.24B | $70.25B |
Dividend Yield | 4.42% | 3.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.
BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.
Public Storage (PSA) trades at $321.86, up 0.41% on the day, with a neutral technical signal and strong profitability metrics including a 39.16% net income margin and 33.78% ROE. Recent earnings beats and the pending acquisition of National Storage Affiliates highlight strategic growth initiatives, supported by a $3.00 dividend and robust cash flow from operations of $3.19B in 2025.
The outlook is positive with a consensus price target of $332.25, though elevated valuation ratios (P/E 33.25) and integration risks from acquisitions pose challenges. Earnings growth and market expansion into Canada are key catalysts, while interest rate sensitivity and competitive pressures remain watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
